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Intestinal epithelial NAIP/NLRC4 restricts systemic
dissemination of the adapted pathogen Salmonella
Typhimurium due to site-specific bacterial PAMP expression
Annika Hausmann1, Desirée Böck2, Petra Geiser1,5, Dorothée L. Berthold1,6, Stefan A. Fattinger1,3, Markus Furter1, Judith A. Bouman4,
Manja Barthel-Scherrer1, Crispin M. Lang1, Erik Bakkeren1, Isabel Kolinko1, Médéric Diard1,7, Dirk Bumann5, Emma Slack1,8,
Roland R. Regoes4, Martin Pilhofer2, Mikael E. Sellin 1,3 and Wolf-Dietrich Hardt1
Inflammasomes can prevent systemic dissemination of enteropathogenic bacteria. As adapted pathogens including Salmonella
Typhimurium (S. Tm) have evolved evasion strategies, it has remained unclear when and where inflammasomes restrict their
dissemination. Bacterial population dynamics establish that the NAIP/NLRC4 inflammasome specifically restricts S. Tm migration
from the gut to draining lymph nodes. This is solely attributable to NAIP/NLRC4 within intestinal epithelial cells (IECs), while S. Tm
evades restriction by phagocyte NAIP/NLRC4. NLRP3 and Caspase-11 also fail to restrict S. Tm mucosa traversal, migration to lymph
nodes, and systemic pathogen growth. The ability of IECs (not phagocytes) to mount a NAIP/NLRC4 defense in vivo is explained by
particularly high NAIP/NLRC4 expression in IECs and the necessity for epithelium-invading S. Tm to express the NAIP1-6 ligands—
flagella and type-III-secretion-system-1. Imaging reveals both ligands to be promptly downregulated following IEC-traversal. These
results highlight the importance of intestinal epithelial NAIP/NLRC4 in blocking bacterial dissemination in vivo, and explain why this
constitutes a uniquely evasion-proof defense against the adapted enteropathogen S. Tm.
Mucosal Immunology (2020) 13:530–544; https://doi.org/10.1038/s41385-019-0247-0
INTRODUCTION
Oral bacterial infection causes localized gastrointestinal disease,
but pathogen dissemination (from here on termed migration) to
systemic sites can lead to life-threatening complications. Multiple
host defenses therefore cooperate to limit mucosal infection and
pathogen spread.1 The intestinal mucus lining and antimicrobial
peptide secretion restrict mucosal invasion.2–7 Intestinal epithelial
cells (IECs) and lamina propria phagocytes mount cell-intrinsic
programs and release pro-inflammatory signals to counter
pathogens that breach this first barrier.2,8–11 Diverse immune cell
types also patrol systemic organs and prevent excessive pathogen
replication.12–15 This multilayered host defense is triggered by
pattern recognition receptors (PRRs) that detect pathogen-
associated molecular patterns (PAMPs), exposed by invading
microbes. However, it is not fully understood which innate
defense mechanisms act at which stage of the infection in vivo
and what quantitative impact can be assigned to each layer of the
defense.
The prototypic enteropathogen Salmonella enterica Typhimur-
ium (S. Tm) colonizes the gut lumen, invades the mucosa, and can
migrate to mesenteric lymph nodes (mLN), spleen, and liver,
causing life-threatening infection, e.g. in immunocompromised
hosts.1 Luminal S. Tm expresses flagella to target gaps in the
mucus layer,4,16 a type-III-secretion system (TTSS-1) to actively
invade IECs,17 and, upon cell invasion, a second TTSS (TTSS-2) to
promote IEC traversal.18 Mononuclear phagocytes (e.g., dendritic
cells (DCs), macrophages) are involved in multiple steps of the
S. Tm infection cycle. They facilitate S. Tm uptake across the
epithelial barrier,19–21 lodge S. Tm within the lamina propria and at
systemic sites,18,22 and act as vessels for S. Tm migration between
organs.23 Consequently, restriction of systemic S. Tm infection may
depend on the capacity of both IECs and phagocytes to recognize
the pathogen through PRR(s) and mount appropriate counter
measures. For an adapted pathogen like S. Tm, this task is
complicated by the bacterium’s evolved ability to evade PRR
recognition, through e.g., context-dependent regulation of its
gene expression or inhibition of host-cell signaling.1,24,25
Inflammasomes are multimeric signaling complexes that
assemble in the host cell cytosol upon sensing of PAMPs or
cellular damage by PRRs of the Nod-like receptor family (NLRs;
NLRP1, NLRP3, NLRC4), Aim2, or Pyrin.26 Inflammasome assembly
causes cleavage of pro-inflammatory Caspase-1,27 secretion of
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interleukin-1 family cytokines and lipid mediators,10,28 and prompt
cell death.29 During bacterial infection, these effects promote
clearance of intracellular pathogens, elicit local inflammation, and
foster recruitment of effector cells, e.g., neutrophils, to sites of
infection.14,30,31 Work in cultured macrophages or DCs established
several inflammasomes capable of responding to S. Tm infection.
NAIP receptors (NAIP1, 2, 5, 6 in mice) recognize the TTSS-1 rod
and needle proteins (NAIP1, 2) or flagellin (NAIP 5, 6) in the
cytoplasm,32–36 and drive assembly of a NAIP/NLRC4 inflamma-
some. NLRP3 can also sense S. Tm infection,37–39 although
the specific ligand(s) detected remains unknown. In addition, a
non-canonical Caspase-4/11 inflammasome directly senses lipo-
polysaccharide (LPS) upon cytosolic escape of S. Tm from the
endosomal compartment.40–42 Inflammasome activation upon
S. Tm infection is not confined to phagocytes, but has also been
shown to occur in epithelial cells, in IECs particularly involving
NAIP/NLRC410,11 or Caspase-4/11.43
The capacity of inflammasomes to restrict S. Tm migration and
growth at systemic sites in vivo has been subject to much debate.
Caspase-1/11-deficient mice showed either reduced or enhanced
susceptibility to systemic S. Tm infection.44–46 NLRC4-deficiency
enhanced susceptibility to systemic infection,44,47,48 but not in all
mouse backgrounds.8 Moreover, Nlrp3−/− mice exhibited identical
disease kinetics as controls,37,44,49 but a functional redundancy
between NLRP3 and NLRC4 during oral S. Tm infection has been
proposed.37,39 Finally, Caspase-11 deletion had no impact on
systemic S. Tm loads,43,50 but one study found higher S. Tm loads
in the gut mucosa during late stage infection.43 It has become
evident that separately held control animals develop a unique gut
microbiota that can deviate considerably from the experimental
group.51–54 This confounding factor may explain some of the
discrepancies between early in vivo S. Tm infection studies.
In a littermate-controlled study of early S. Tm gut infection we
identified IEC NAIP/NLRC4 as a key mucosal defense, which drives
expulsion of infected IECs to limit mucosal tissue S. Tm loads.11
Protection by epithelial NLRC4 was confirmed in a subsequent
study,10 and also pertains to Citrobacter rodentium infection.55
Importantly, mice globally lacking NAIP proteins also featured
elevated systemic S. Tm loads upon oral challenge.11 Due to the
central involvement of phagocytes in pathogen migration and
growth at systemic sites, this raised the question if NAIP/NLRC4
within IECs, phagocytes, or both, restrict disseminated S. Tm
infection. Moreover, it remained unclear if pathogen restriction
also involved NLRP3 and/or Caspase-11 and whether redundan-
cies between the inflammasomes exist in vivo.
Here, we applied a bacterial population dynamics approach and
littermate-controlled infections of inflammasome-deficient mice
to address which inflammasome(s) in which cell types restrict
disseminated oral S. Tm infection. We find that S. Tm successfully
escapes restriction by phagocyte inflammasomes that in principle
can recognize the bacterium. By contrast, the necessity for S. Tm
to express the NAIP ligands—flagella and TTSS-1—during the
epithelial cell invasion step explains why intestinal epithelial NAIP/
NLRC4 constitutes a unique restriction system that even this
highly adapted pathogen cannot fully evade.
RESULTS
NAIP/NLRC4 potently restricts S. Tm migration from the gut lumen
to systemic sites
Our in vivo analysis of the NAIP/NLRC4-mediated defense focused
on the S. Tm infection dynamics during the first 24h after
orogastric inoculation in the Streptomycin pretreated mouse
model.56 Due to its highly reproducible, fast and robust kinetics,
this infection setup is ideally suited to study innate immune
restriction of enteropathogen dissemination to systemic sites.
Within 24 h, the pathogen colonizes the gut lumen of Strepto-
mycin pretreated mice, invades the gut mucosa, and disseminates
systemically via gut-draining mLN.57 The size of a pathogen
population inside the mLN is the product of several parameters,
i.e., bacterial immigration to this site, replication on the way to and
within the organ, emigration to other sites and elimination of the
pathogen by the host. In contrast to classical selective plating of
infected organs, which merely provides a snapshot of the bacterial
population size, infections with mixtures of wild-type isogenic
tagged strains (WITS), combined with mathematical modeling can
reveal the dynamic parameters and thereby provide essential
information on pathogen restrictive mechanisms (Fig S1).58–63
To establish the quantitative infection parameters, we infected
Streptomycin pretreated mice with a mixed inoculum (5 × 107
total CFU per gavage), comprised of non-tagged S. Tm and seven
WITS each spiked in at a 1:140 dilution (i.e., the WITS strains
together made up 5% of the inoculum). By conventional plating,
we detected ~10-fold increased total S. Tm loads in the mLN of
Nlrc4−/−64 mice compared to their heterozygous littermate
controls at 24 h post-infection (hpi) (Fig. 1a, “all S. Tm”). This
phenotype was confirmed by selective plating of the WITS
population (Fig. 1a, “WITS”). In line with earlier work establishing
that gut luminal S. Tm loads are independent of gut inflammation
during the first 24h,65 we did not detect any changes in luminal
colonization (Fig S2A). To determine the cause of the elevated
mLN pathogen loads, we analyzed the number of distinct WITS
recovered from this organ. In the mLN of infected Nlrc4−/− mice
all, or close to all, of the seven WITS were recovered at 24 hpi. By
striking contrast, Nlrc4+/− littermate control mLN harbored on
average only two WITS (Fig. 1b).
The higher diversity of WITS in the mLN of Nlrc4−/− mice
suggested that more bacteria seed the organ to give rise to the
mLN-lodged pathogen population. To test this hypothesis,
we applied a mathematical model for analysis of population
dynamics, considering pathogen migration (µ) and net growth
(r59; see materials and methods for details). This established that
the S. Tm migration rate (µ) from the cecal lumen to the mLN
was elevated by 8.7-fold in Nlrc4−/− mice compared to controls
(Fig. 1c). Notably however, the presence or absence of NLRC4
did not affect the pathogen's net replication rate (r) within the
mLN (Fig. 1d). We repeated these experiments in Naip1-6Δ/Δ66
mice, which lack the receptors activating the NLRC4 inflamma-
some.66 These mice phenocopied Nlrc4−/− animals, showing a
6.7-fold increase in S. Tm migration to the mLN, but a similar
within-mLN pathogen replication rate as control animals
(Fig. 1e–h, S2B).
Taken together, these findings show that the NAIP/NLRC4
inflammasome is of key importance for restricting S. Tm migration
from the gut lumen to the mLN, but does not affect the
pathogen's replication within this target organ. By inference, this
indicates that phagocyte NAIP/NLRC4 is dispensable for control-
ling pathogen growth in the mLN. It remained to be established if
IEC or phagocyte NAIP/NLRC4 could explain restriction of
pathogen migration from the gut, and if additional inflamma-
somes also impact this process.
NLRP3 and Caspase-11 are dispensable for control of S. Tm
dissemination from the gut, even in the absence of NLRC4
The significance of the NLRP3 inflammasome and the non-
canonical Caspase-11 inflammasome during oral S. Tm infection
and their role in limiting pathogen levels at systemic sites are
ambiguous.11,37,39,43,49,50 To quantitatively assess the involvement
of these inflammasomes, we infected Nlrp3−/−67 and Casp11−/−41
mice using the experimental setup described in Fig. 1. We did not
observe any difference between the total bacterial loads in the
cecal lumen and mLN, the WITS loads, or the numbers of WITS
recovered from the mLN of either knockout line, when compared
to their respective littermate controls (Fig S2C-D, S3A-B). More-
over, mathematical inference confirmed equivalent values for
migration (µ) and net replication (r) in knockouts and controls
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(Fig. 2a, b; values for Nlrc4−/− mice replotted from Fig. 1c, d for
comparison). Hence, neither NLRP3, nor Caspase-11, impact the
dynamic parameters of oral S. Tm dissemination. Casp1/11−/−68
mice featured an intermediate phenotype with regards to total
mLN pathogen loads, which were increased ~3-fold (Fig S3C),
while luminal colonization (Fig S2E), migration and replication of
the bacterium were not altered (Fig. 2a, b). These data agree with
a previously reported partial, but non-absolute, dependence of
NAIP/NLRC4 on Caspase-1.10,11,69,70
As NAIP/NLRC4 potently limits pathogen migration (Fig. 1), we
reasoned that the lack of involvement of NLRP3 and Caspase-11
might be attributable to redundancies with this inflammasome.
We thus crossed Nlrc4−/− mice with Nlrp3- or Casp11-knockout
animals to obtain Nlrc4−/−Nlrp3+/− and Nlrc4−/−Nlrp3−/− litter-
mates, as well as Nlrc4−/−Casp11+/− and Nlrc4−/−Casp11−/−
littermates, for infections. However, also in an Nlrc4−/− back-
ground, neither Nlrp3-ablation nor Casp11-ablation affected
pathogen migration (µ) to the mLN, pathogen replication (r), total
S. Tm loads in this organ by 24 hpi (Fig. 2c, d, Fig S3D-E), or cecal
luminal growth (Fig S2F-G). In line with these data, we did not
detect significant differences in mucosal inflammation between
the mice (Fig S4). Thus, we conclude that in our oral infection
model, NLRP3 and Caspase-11 are not involved in the control of S.
Tm dissemination from the gut lumen during the first day of
infection. As our approach monitors all infection steps from the
gut lumen to the mLN, these data should exclude an impact of IEC
and phagocyte NLRP3 and Caspase-11, alike.
NAIP/NLRC4 in IECs, not in phagocytes, restricts systemic spread of
S. Tm from the gut lumen
The population dynamics analysis revealed that NAIP/NLRC4
restricts migration (µ) of S. Tm from the intestinal lumen to the
mLN, but appears dispensable for containment of pathogen
replication (r) within the mLN. The parameter µ in the model
summarizes two main steps of the infection process: (i) the
invasion/translocation of S. Tm across the cecal mucosa and (ii) the
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Fig. 1 The NAIP/NLRC4 inflammasome restricts pathogen migration to the mLN during oral S. Tm infection. Streptomycin pretreated mice
were orally infected with 5 × 107 CFU S. Tm. a S. Tm counts (colony forming units, CFU) in the mLN at 24 hpi in Nlrc4−/− mice (open circles) are
~10-fold increased compared to Nlrc4+/− (circles) littermates. b The populations recovered from the mLN of Nlrc4−/− mice (open circles)
display higher variety in WITS than those isolated from Nlrc4+/− (circles) littermates. Analysis of mice depicted in a. Only mice with detectable
WITS (plating) in the mLN were included in the analysis, remaining samples were set to 0. c The migration rate µ from the cecal lumen (of mice
shown in b with ≥1 WITS-CFU per mLN, translocation events/day) to the mLN of Nlrc4−/−mice (open circles) is 8.7-fold increased compared to
Nlrc4+/− (circles) littermates. d S. Tm growth rate r within the mLN (of mice shown in b with ≥1 WITS-CFU per mLN, depicted as growth rate
per day) is independent of NLRC4. e S. Tm counts in the mLN of Naip1-6Δ/Δ mice (open circles) are ~10-fold increased at 24 hpi compared to
Naip1-6fl/Δ (circles) littermates. f The populations recovered from the mLN of Naip1-6Δ/Δ mice (open circles) display higher variety in WITS than
that of Naip1-6fl/Δ (circles) littermates. Analysis of mice depicted in e. Only mice with detectable WITS (plating) in the mLN were included in the
analysis, remaining samples were set to 0. g The migration rate µ from the cecal lumen (of mice shown in f with ≥1 WITS-CFU per mLN,
translocation events/day) to the mLN of Naip1-6Δ/Δ mice (open circles) is 6.7-fold increased compared to Naip1-6fl/Δ (circles) littermates. h S. Tm
growth rate r within the mLN (of mice shown in f with ≥1 WITS-CFU per mLN, depicted as growth rate per day) is independent of NAIP1-6.
Depicted are counts of all S. Tm (dark blue, selected for with Streptomycin) and specifically of the WITS (light blue, selected for with
Kanamycin, 5% of inoculum). Each circle represents one mouse. Combined data of three (e–h) or four (a–d) independent experiments. Dotted
line: detection limit. Gray line: Median, in c, d, g, and h 95%-Confidence Intervals are indicated. Statistical analysis: Mann-Whitney-U Test,
p-values indicated, ns: p ≥ 0.05.
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subsequent transport of the pathogen from the mucosa into the
mLN. To specify which of the two components is impacted by
NAIP/NLRC4, and in which cell type the restriction takes place, we
infected mice lacking the NAIP receptors specifically in IECs
(Naip1-6Δ/ΔIEC). Surprisingly, we found that IEC-specific ablation of
NAIPs was sufficient to reproduce the pathogen migration
phenotype observed in full body Naip1-6 knockouts (Fig. 3a,
compare with Fig. 1), while luminal colonization was unaffected
(Fig S2H). The replication parameter (r) remained unaffected in
Naip1-6Δ/ΔIEC animals (Fig. 3a), further supporting a role for IEC
NAIP/NLRC4 specifically in preventing pathogen migration from
the gut lumen.
Notably, the restriction of systemic bacterial loads by epithelial
NAIP/NLRC4 was equally relevant in an infection with a different S.
Tm strain (S. Tm14028; Fig S5A, S2L). This suggests that the
epithelial inflammasome is of general relevance for protection
against S. Tm strains.
Active epithelial invasion, most prominently in the cecum,4 is
the main pathway by which S. Tm traverses the intestinal
epithelium to reach the mLN in the Streptomycin mouse model.
By contrast, passive pathogen transport via lymphoid follicles and/
or gut lumen-sampling DCs accounts for only ~10% of the total
transport.19,57 Due to the pronounced effect of the IEC NAIP/
NLRC4 inflammasome, it remained unclear if this “alternative”
sampling route for traversal might also be restricted by the NAIP/
NLRC4 inflammasome. The S. Tm mutant S. TmΔ4 (SL1344
sipAsopBsopEsopE2) lacks the TTSS-1-delivered effector proteins
necessary for active invasion into IECs, but retains the TTSS-1
structural components sensed by NAIP/NLRC4.71 While being
severely attenuated for IEC invasion, non-invasive mutants like
S. TmΔ4 can still traverse the epithelial barrier by the passive
sampling route.19 Hence, this strain only rarely passes through
IECs on the way from the gut lumen to the mLN, but instead
promptly enters the lamina propria phagocyte compartment. This
feature allowed us to specifically analyze the impact of phagocyte
NAIP/NLRC4 on the pathogen migration rate. Towards this aim, we
applied the same procedure as described in Fig. 1. We infected
Nlrc4−/− mice for 24h with a mixture of non-tagged S. TmΔ4 and
spiked in the seven barcoded WITSΔ4 strains at a 1:21 dilution (i.e.,
the WITSΔ4 strains together made up 33.3% of the inoculum). In
line with this strain only migrating through the passive sampling
pathway, the absolute mLN loads of S. TmΔ4 were ~10-fold lower
than in an infection with wildtype S. Tm (compare Fig. 3b with
Fig. 1a) and no detectable mucosal pathology was induced at
24 hpi (Fig S4C). This is in line with earlier work indicating that
sipAsopBsopEsopE2-mediated epithelium invasion is the key
trigger of acute mucosal inflammation.72,73 Importantly, when
infecting with S. TmΔ4,, we did not observe any effect of the
ablation of NLRC4 on the mLN infection dynamics and cecal
lumen colonization (Fig. 3b, S2I). This was also the case for
Naip1-6Δ/ΔIEC mice (Fig. 3c, S2K). It is interesting to note that we
observed a slight, but non-significant trend towards higher mLN
counts in Naip1-6Δ/ΔIEC mice. We suspect that this is attributable to
some residual epithelial invasion capacity of S. TmΔ4 19,74 and/or
uptake by M-cells.
Finally, to formally exclude the involvement of DC NAIP/NLRC4
in S. Tm restriction, we infected mice lacking the NAIP receptors
specifically in CD11c+ cells (Naip1-6Δ/ΔCD11c) with wild type S. Tm
as described above. In line with our previous observations, the
ablation of Naip1-6 in CD11c+ cells did not affect luminal
colonization (Fig S2M), mLN pathogen loads, migration of S. Tm
to the mLN and replication of the bacterium at this site (Fig S5B).
Altogether, these data demonstrate that i) NAIP/NLRC4 specifically
in IECs acts as a firewall against pathogen dissemination from the
gut lumen, whereas ii) this inflammasome has minimal impact in
phagocyte populations that take up S. Tm in the mucosa, transport
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the pathogen to the mLN, or lodge the bacteria within this
site.18,19,23
NLRC4, NLRP3 and Caspase-11 inflammasomes are all dispensable
during early systemic S. Tm infection
As a more direct test for a possible involvement of phagocytes in
inflammasome-mediated containment of S. Tm, we employed a
systemic infection model. Here, S. Tm (104 CFU) were applied
intravenously (iv), resulting in a rapid uptake by phagocytes, and
subsequent pathogen growth in the spleen and other systemic
organs within 6-10 hpi.58,75 In this model, the main lymphoid
organ infected during the first 2 days is the spleen, which was
analyzed here (Fig. 4) at 24 hpi, analogously to the mLN in the oral
infection model (Figs. 1–3). For estimation of µ and r, the inoculum
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increased in Naip1-6Δ/ΔIEC mice (open circles) compared to Naip1-6fl/fl littermates (circles) and phenocopied Naip1-6Δ/Δ mice (compare
Fig. 1e–h). Growth rate r within the mLN was independent of NAIP1-6 within IECs. b Streptomycin pretreated mice were orally infected with
5 × 107 CFU S. TmΔ4. S. TmΔ4, which bypasses IECs, is unaffected by NLRC4-mediated restriction during migration to and colonization of the
mLN. This extends to epithelial NAIP1-6 (c). Depicted are counts of all S. Tm (dark blue, selected for with Streptomycin) and specifically of the
WITS (light blue, selected for with Kanamycin, 5% of the inoculum) or S. TmΔ4 (dark green, selected for with Streptomycin) and specifically of
the WITSΔ4 (light green, selected for with Kanamycin, 33.3% of the inoculum). Each circle represents one mouse. Combined data of two (b, c)
or three (a) independent experiments. Dotted line: detection limit. Gray line: Median, for µ and r, 95%-Confidence Intervals are indicated.
Statistical analysis: Mann-Whitney-U Test, p-values indicated, ns: p ≥ 0.05.
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was spiked with the seven barcoded WITS in a dilution of 1:700
(i.e., the WITS strains together made up 1% of the inoculum).
Strikingly, when analyzing spleen S. Tm loads in Nlrc4−/− mice
and littermate controls, we found NLRC4 to be completely
dispensable for pathogen control. In line with this, we did not
detect any differences in the number of WITS recovered from the
spleen of these mice. Furthermore, the migration rate µ and the
replication rate r within the spleen were not altered upon ablation
of NLRC4 (Fig. 4a). We also observed no effect of NLRP3, or
Caspase-11, on the containment of systemic S. Tm infection, even
when analyzed in an Nlrc4−/− background (Fig. 4b, c). Casp1/11−/−
mice again featured an intermediate phenotype, similar to our
observations in the oral infection model, i.e., ~3-fold increased
bacterial loads in the spleen by 24 hpi (Fig. 4d, compare to
Fig S3C). Mathematical modeling suggests that this effect is due to
a Caspase-1 mediated restriction of initial S. Tm migration to the
spleen, rather than involvement in suppression of pathogen
replication within this organ (Fig. 4d, population structure, µ and
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r). Hence, our data refute a significant impact of NLRC4, NLRP3 and
Caspase-11 during early systemic S. Tm infection, while Caspase-1
contributes modestly to the control of pathogen loads. This
resolves long-standing controversies in the literature about the
involvement of different inflammasomes in host responses to
wildtype S. Tm infection.37,39,43,47,49,50,76 It should be noted that
differences in the studied infection time points or distinct
virulence factor expression patterns of the employed S. Tm strains
may also account for disparate phenotypes. Nevertheless, in our iv
infections, Caspase-1 mediated defense appears independent of
NLRC4, NLRP3, or Caspase-11. It remains to be established which
other activation pathway might be involved.
IECs express more Naip and Nlrc4 transcripts than the remaining
mucosal tissue cell types
To assess the NAIP/NLRC4 sensing potential of the specific cell
types that interact with S. Tm during oral infection in mucosal and
systemic tissues, we analyzed Naip/Nlrc4 expression by quantita-
tive PCR (qPCR). For assessment of Naip transcript levels in IECs vs.
other cells of the mucosa (including phagocytes), and to set the
baseline of the assay, we initially compared tissues from
uninfected wildtype mice (Naip1-6fl/fl), to those of Naip1-6Δ/ΔIEC
and Naip1-6Δ/Δ animals. Mice carrying just one intact allele of the
Naip1-6 locus (Naip1-6fl/Δ) served as an additional control for the
sensitivity of the assay.
Nlrc4 and Naip1, 2, 5, and 6 expression levels were markedly
higher in the cecum tissue, as compared to both mLN and spleen
(Fig. 5a–e, data from Naip1-6fl/fl mice). Nlrc4 was expressed at ~10-
fold higher levels in the cecal mucosa than in the mLN and around
100-fold higher than in the spleen (Fig. 5a). Similar differences
could be observed for the Naip transcripts. Especially Naip1 was
strongly expressed in the cecum, but ~100-fold reduced in the
spleen (Fig. 5b). The bulk of the cecal Naip1, 2, 5, and 6 expression
was attributable to IECs, in agreement with earlier work by us and
others11,77 (Fig. 5b–e, compare Naip1-6fl/fl with Naip1-6Δ/ΔIEC).
Interestingly, when we analyzed the liver as a non-barrier, non-
lymphoid organ, we found that the expression levels of Nlrc4 and
Naip1-6 were generally ~100-fold lower than in the cecal mucosa
(Fig S6A-B, compare to Fig. 5a–e). Hence, the cecal epithelium
appears to be particularly loaded with NAIP/NLRC4 for detection
of invading pathogens. This charging of non-immune cells with
inflammasome receptors might be particularly pronounced in
barrier tissues that are in close contact with microbes and engage
actively in defense.10,11,43,55,78
In addition to the major epithelial Naip transcript pool, we
noted a significant contribution from other cell types to the
expression of the Naip genes in the cecal mucosa (Fig. 5b–f,
compare Naip1-6Δ/ΔIEC and Naip1-6Δ/Δ animals). From the available
dataset we could not infer to what percentage various immune
cells, fibroblasts, endothelium and/or other cell types contribute to
this non-IEC expression. To specifically analyze the expression of
Naip/Nlrc4 in intestinal DCs—the cell type that has been reported
to take up S. Tm in the cecal mucosa and transport it to the
mLN19,23—we sorted intestinal DC subsets from wildtype LPS-
injected mice and PBS vehicle controls. Whereas Nlrc4 was
expressed equally in all intestinal DC subsets, CD103+ DCs
expressed Naip1 and Naip2 at increased levels compared to other
subsets (Fig S6C). The expression of these receptors was not
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boosted by exposure to the pro-inflammatory stimulus LPS. In fact,
LPS-priming rather led to a downregulation of expression in some
of the DC subsets, which might be explained by the immuno-
tolerant phenotype of mucosal myeloid cells.79 In addition, this
downregulation might represent a protective mechanism by
which self-destruction of infected DCs is prevented to ensure
antigen presentation.
Taken together, our data highlight that IECs express particularly
high levels of Naip and Nlrc4 transcripts, whereas DCs encoun-
tered by S. Tm subsequent to epithelial traversal and/or upon
passive sampling appear to express more modest levels.
Importantly though, the failure of DCs to restrict S. Tm
dissemination through NAIP/NLRC4 in vivo cannot be explained
by a complete lack of this inflammasome. However, the reduced
expression levels (compared to IECs) might explain why S. TmΔ4
dissemination is not efficiently restricted by NAIP/NLRC4 (Fig. 3).
S. Tm expresses the NAIP ligand structures TTSS-1 and flagella
during IEC invasion, but promptly downregulates them upon
transit to the lamina propria and systemic tissues
S. Tm migration to systemic sites is potently restricted by IEC NAIP/
NLRC4, but apparently not by phagocyte NAIP/NLRC4, even
though both cell types express detectable levels of the required
receptors (Figs. 3–5; Fig. S6C). One reason for this discrepancy
might reside in the pathogen's gene expression program, which
may prevent PAMP expression at certain sites. Such compartment-
specific down regulation has been observed previously in various
infection models.25,80–82 S. Tm requires TTSS-1 and flagella
(composed of flagellin subunits) for the initial colonization and
establishment of gut infection.16,72 Especially for invasion of IECs,
which strongly express Naip1, 2, 5, 6, and Nlrc4 (Fig. 5a–e), the
NAIP ligand structures TTSS-1 (for the delivery of the effector
proteins SipA, SopB, SopE, and SopE2)72,73 and flagella (to subvert
gaps in the mucus layer and reach the epithelium by directed
motility)4,16 are both crucial. This could explain why infection
events are efficiently sensed and restricted specifically by IEC
NAIP/NLRC4. However, it remained unclear to which extent S. Tm
regulates TTSS-1 and flagella expression during and after
epithelium traversal.
To clarify this aspect, we assessed the expression of NAIP-
activating S. Tm PAMPs during the infection process. Initially, we
optimized staining procedures in S. Tm infections of cultured HeLa
epithelial cells, a process that relies on TTSS-1 (TTSS-1-deficient
mutants ~500–1000-fold attenuated)74 and flagella-driven moti-
lity.16 While HeLa cells are clearly a simplistic test system riddled
by genetic drift83 they nevertheless provide an efficient test
system for establishing microscopy analysis pipelines. Notably,
when infected HeLa cells were immunostained for the flagella
subunit FliC, we could detect a significant fraction of FliC+ S. Tm
also within the epithelial cells (Fig S7A). Notably, ~30% of the
bacteria still stained positive for FliC at 7 hpi (Fig S7B). This is in
line with previous work.84 These findings were supported by
parallel analyses of infected HeLa cells using cryo-focused ion
beam (cryo-FIB) milling and cryo-electron tomography (cryoET).
Cryotomograms showed fully assembled flagella located between
the bacterial surface and the membrane of the Salmonella
containing vacuole (SCV) (Fig. 6a).
Previous work has shown that a subfraction of S. Tm may
escape the SCV over time and become cytosolic.81,85 When we
analyzed the cytosolic subpopulation with the help of S.
Tmlocalizer, carrying a reporter for cytosolic escape (pCK100,
glucose-6-phosphate (Glc6P)-driven expression of mCherry),86–89
we found that at 7 hpi, around one quarter of all the cytosolic
bacteria was FliC+ (Fig S7B). Strikingly, we frequently detected
bacteria with protruding flagella (Fig S7A, S7C). Cryotomograms,
however, indicated a tight enclosure of both bacterium and
flagellum within the SCV (Fig. 6a). Indeed, cytosolic localization
correlated with a protruding flagellum conformation (Fig S7C).
These data suggest that in addition to the mandatory expression
of TTSS-1, a significant fraction of S. Tm carry flagella within
cultured epithelial cells, and maintain or re-express these during
egress into the cytosol, which is in line with observations by
Knodler et al..84 These cytosolic S. Tm carrying the flagellum might
be a potent trigger of epithelial inflammasome activation.
Results from immortalized cell lines exhibit limited reproduci-
bility to in vivo settings due to altered cell physiology and lack of
tissue environment.83,90,91 We therefore assessed if our observa-
tions also apply in vivo during IEC infection in the mouse model.
We infected mice orally with S. Tm carrying a transcriptional
reporter (prgH-GFP) for TTSS-1 expression (S. TmSPI-1-GFP) and
analyzed the pathogen populations in the cecum tissue (12 hpi)
and at systemic sites (spleen, 3 dpi to obtain sufficient bacterial
loads). Fluorescence microscopy was used to assess TTSS-1
expression (i.e., prgH-GFP) and flagella expression (staining with
anti-FliC antibodies). Around 80% of the S. Tm lodged in IECs were
SPI-1+ (Fig. 6b–d). This sharply contrasted to SPI-1 expression in
the lamina propria (~20% SPI-1+ S. Tm) and the spleen (no
detectable SPI-1 expression) (Fig. 6b–d). In line with the tissue
culture data above, ~50% of the S. Tm lodged in the cecal
epithelium also stained positive for FliC (Fig. 6e–g). This
population was increased two-fold in the absence of epithelial
NAIP receptors (Fig S8A), which correlated with a significantly
increased fraction of cytosolic bacteria, especially with regard to
microcolonies consisting ≥4 bacterial cells, in Nlrc4−/− mice
compared to Nlrc4+/− or wildtype mice (Fig S8B). These
observations are consistent with NLRC4/NAIP-dependent expul-
sion of IECs containing flagellated S. Tm. By contrast, we detected
significantly less FliC+ S. Tm in the lamina propria (Fig. 6f, g) and
no FliC+ bacteria in the spleen (Fig. 6e, g). It is currently not
entirely clear if fully assembled flagella structures can activate the
NAIP/NLRC4 inflammasome. Nevertheless, one can take the
flagella as a proxy for the presence of flagellar subunits. Assuming
that 90% of the lamina propria-lodged pathogens have reached
this site by traversing the IECs (which necessitates the expression
of PAMPs recognized by NAIP/NLRC4), our data indicate that the
pathogen promptly down regulates expression of both structures
during transit, thereby evading recognition by phagocyte NAIP/
NLRC4.
To formally test if PAMP down regulation explains S. Tm evasion
of phagocyte NAIP/NLRC4-restriction, we analyzed the effect of
forced PAMP expression. This strategy has been used in the past
to assess the PAMP-specificity of individual inflammasomes.92 To
this end, we infected Nlrc4+/− and Nlrc4−/− littermate mice iv with
a 1:1 mix of S. TmECV (S. TmΔflgB TAG13 (pZ2500); empty control
vector) and S. TmfliCind (S. TmΔflgB TAG1 (pEM087); expression of FliC
under a Doxycycline-inducible promoter14). We induced FliC
expression by iv Doxycycline administration at 17 hpi, a time
point when most of the bacteria should be lodged within splenic
phagocytes. In NLRC4 proficient hosts, splenic S. TmfliCind loads
were ~10-fold lower than those of S. TmECV by 24 hpi (Fig S9).
Notably, this phenotype was not observed in Nlrc4−/− mice
(Fig S9). Thus, splenic phagocytes are able to sense S. Tm via the
NAIP/NLRC4 inflammasome, but S. Tm as a rule avoids recognition.
This further supports that downregulation of PAMP expression
upon traversal of the gut epithelium contributes to S. Tm evasion.
DISCUSSION
Earlier work has implicated NAIP/NLRC4 in host defense against S.
Tm and related enteropathogens.8,10,11,30,44,47,55 Mice globally
lacking key components of this inflammasome suffer from
exacerbated systemic infection and higher pathogen loads in
lymph nodes, spleen and liver upon oral inoculation.8,10,11,37,44,47
As mechanistic work on NAIP/NLRC4 signaling has focused on
phagocytic cell types,26 and as S. Tm frequently lodge within such
cells at extraintestinal locations,58 it has been assumed that
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phagocytes mediate protection of systemic organs via NAIP/
NLRC4. In sharp contrast, our analysis proves phagocyte NAIP/
NLRC4 to be dispensable for restriction of S. Tm migration to, and
replication at, systemic sites (Figs. 1, 3, 4, S5A) during early
infection. This pertains also to an S. Tm strain that enters promptly
into lamina propria phagocytes upon passive uptake of luminal
bacteria (S. TmΔ4; Fig. 3b, c). Instead, our data show that
inflammasome defense against dissemination of different S. Tm
strains from the gut relies specifically on intestinal epithelial NAIP/
NLRC4 (Fig. 3, S5), previously shown to drive the expulsion of
infected IECs and restrict mucosal pathogen loads by >>50-fold
during oral S. Tm or Citrobacter rodentium infection.11,55 These
results establish IEC NAIP/NLRC4 as the warden of not only the gut
mucosa, but also of the systemic compartment, upon infection
with a host-adapted pathogen.
The expression levels of Naip and Nlrc4 transcripts are notably
high in IECs, but also clearly detectable across systemic organs
and mucosal tissue DCs (Fig. 5, Fig. S6). On top of this, the
downregulation of NAIP-activating PAMPs within host tissues
provides an explanation to the failure of phagocytes, but ability of
IECs, to utilize NAIP/NLRC4 for combatting S. Tm in vivo (Fig. 6,
Fig S7–S8).
Following flagella- and TTSS-1-driven invasion of IECs, which by
necessity exposes these PAMPs to epithelial NAIP receptors, S. Tm
promptly downregulates expression of both structures, thereby
preventing NAIP/NLRC4 activation beyond the epithelial barrier
(Fig. 6, Fig S8–S9).93 Other evasion mechanisms, e.g., SCV
membrane shielding of PAMPs from the cytosolic NAIPs, and
active interference by secreted virulence factors, might further
dampen residual inflammasome activation in a cell-type specific
manner.1,24 Also, it remains to be fully shown how polymerization
into the flagellum affects the NAIP/NLRC4 triggering intensity of
flagellin. Anyhow, the evasion of recognition is possibly already
employed during IEC-invasion, but may be hampered by high
bacterial invasion rates and relatively long lifetimes of the
bacterial proteins. Nevertheless, even when administered systemi-
cally, S. Tm is not recognized by phagocyte NAIP/NLRC4, except if
expression of the flagella component FliC, a NAIP5-6 ligand, is
artificially forced (Fig. 4, Fig S9).92 Therefore, while phagocytes at
systemic sites would indeed be capable of pathogen restriction via
NAIP/NLRC4 (Fig. 5, Fig S9), our population dynamics data
conclusively show that different S. Tm strains evade this defense.
This is in stark contrast to less-well adapted bacteria, like
Chromobacterium violaceum, which are vigorously restricted
(>>1.000-fold in liver) by the NAIP/NLRC4 inflammasome in
systemic organs.94 Based on these observations, it is tempting
to speculate that mechanisms for avoiding the NAIP/NLRC4
defense have contributed to the evolution of gene-regulatory
circuits in host-adapted bacterial pathogens.
Other inflammasomes have previously been deemed protective
during S. Tm infection in mice.37,39,43 However, under stringent
littermate-controlled conditions, we here find that neither NLRP3,
nor Caspase-11, impact S. Tm transmucosal migration or early
systemic replication in vivo, at least in the Streptomycin
pretreated mouse model (Fig. 2). Caspase-11 can protect against
systemic infection by bacteria colonizing the host cell's cytosol,
e.g., Burkholderia spp.40 Other intracellular pathogens, including S.
Tm and Legionella pneumophila (L. pn), express virulence factors
that stabilize the intracellular vacuole.88,95 Mutant S. Tm and L. pn
strains lacking those factors breach the vacuolar membrane with
higher frequency and are efficiently detected by Caspase-11.40,42
Our finding that Caspase-11 is dispensable for restriction of S. Tm
dissemination/replication (Fig. 2, Fig S3) agrees with these reports,
supporting that wildtype S. Tm evades Caspase-11 recognition
after oral infection in vivo. Importantly, deletion of Casp11 in
Nlrc4−/− mice does not increase pathogen migration or systemic
colonization (Figs. 2, S3, 4). This refutes the possibility that a
potent epithelial NAIP/NLRC4 response masks any effect of
Caspase-11. Furthermore, Casp1/11−/− animals only partially
recapitulate the elevated S. Tm dissemination of NAIP1-6 or
NLRC4-deficient animals (Figs. 2, S3, 4). This points to the potential
involvement of also other Caspases, e.g., Caspase-8,10 in the
execution of the IEC NAIP/NLRC4 response. The molecular wiring
of this defense system will be an important topic for future work.
During acute infection, NLRP3 does not contribute to restriction
of S. Tm infection neither in the gut mucosa (Fig. 2, Fig S3), nor at
systemic sites (Fig. 4), not even in the absence of NLRC4 (Figs. 2,
S3, 4). This contrasts to previous reports in the literature.37,39 We
can only speculate about the origins of this discrepancy. Our
results apply to different, widely used S. Tm strains (SL1344 and
14028), rendering the use of different strains an unlikely cause. It
might be attributable to the huge impact of the intestinal
microbiota on non-typhoidal Salmonella infection models, as well
as to small differences in genetic backgrounds that have recently
been revealed.51–53 These could have been confounding in
experiments using separately bred wildtype mice as controls
rather than littermates. Again, the lack of an NLRP3-linked
response may also be explained by efficient S. Tm evasion of
this inflammasome.96 Furthermore, NLRP3 and/or Caspase-11 may
serve some more specific function(s) during late stages of a
persistent infection or in hosts other than mice.
Taken together, our data extend previous
work,10,11,37,39,42,44,45,47,49,50,76 highlight that in vivo studies of
host–pathogen interactions are highly sensitive to the experi-
mental conditions, and may be subject to confounding effects
that limit reproducibility. The general approach presented here—a
combination of littermate controlled infections, host cell type-
specific gene knockouts, genetically tagged bacterial consortia,
mathematical modeling and high-resolution imaging of the
infected cells/organs—allowed us to decipher the impact of
specific host responses in vivo. Here, this led us to refute a
protective function for phagocyte inflammasome defense and to
uncover intestinal epithelial NAIP/NLRC4 as a firewall preventing
systemic dissemination of the orally acquired adapted pathogen S.
Tm. We expect the same approach to be powerful for (re-)
assessing also the impact of other barriers during the step-wise
progression of infectious disease, with extension to other
pathogens.
METHODS
Salmonella strains and growth conditions
Strains used in this study are S. Tm SL1344 (SB300, Streptomycin
resistant), or derivatives thereof, except for S. Tm14028 97 and
WITS14028. S. TmΔ4 lacks four TTSS-1 effector proteins (sipA, sopB,
sopE, sopE2), but still expresses the TTSS-1 secretion apparatus,
and was described previously.71 The tags for the WITS strains as
described in ref.,58 were introduced by P22 phage transduction.
We used S. Tm carrying pM975 (S. TmSPI-2-GFP)72 as a reporter for
SPI-2 expression (S. Tm,SPI-2 within the SCV), S. Tm expressing GFP
under a prgH-promotor (JH3010, S. TmSPI-1-GFP) to mark SPI-1
expressing bacteria (S. TmSPI-1), S. Tm carrying pCK100 (Glc6P-
driven mCherry expression, S. TmGlc6P-mCherry) as a reporter for
cytosolic bacteria (S. TmGlc6P) and S. Tmlocalizer expressing GFP
under the ssaG promotor (JH3009) and carrying pCK100 to track
SCV/cytosolic localization of S. Tm. pCK100 was constructed as
follows: A 137 bp genomic fragment immediately upstream of the
uhpT gene in Shigella flexneri 2a 2457T (GenBank: AE014073.1,
3869168...3869032) was cloned upstream of the ribosomal binding
site of phage T7 gene 10 and mCherry on a pSC101 backbone. S.
Tm carrying this plasmid showed induced red fluorescence when
cultured in presence of Glc6P but not in presence of glucose. As
Glc6P is specifically present in the host cell cytosol, this is a
reporter plasmid for cytosolic localization, as described previously
for Shigella flexneri.98 S. TmΔfliGHI carrying pM975 (pssaG-GFPmut2)
was used as a control for specificity of the FliC staining. S. TmfliCind
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the. . .
A Hausmann et al.
539
Mucosal Immunology (2020) 13:530 – 544
Ta
bl
e
1.
St
ra
in
s
u
se
d
in
th
is
st
u
d
y.
St
ra
in
n
am
e
in
m
an
u
sc
ri
p
t
St
ra
in
n
u
m
b
er
R
el
ev
an
t
g
en
o
ty
p
es
C
o
m
m
en
t
R
es
is
ta
n
ce
s
R
ef
er
en
ce
SL
13
44
SB
30
0
w
ild
ty
p
e
R
ef
er
re
d
to
as
S.
Tm
Sm
1
0
6
SB
30
0T
A
G
1
M
31
47
Ta
g1
-a
ph
T
C
o
lle
ct
iv
el
y
re
fe
rr
ed
to
as
W
IT
S
Sm
,K
m
5
9
SB
30
0T
A
G
2
M
31
48
Ta
g2
-a
ph
T
Sm
,K
m
SB
30
0T
A
G
1
1
M
31
49
Ta
g1
1-
ap
hT
Sm
,K
m
SB
30
0T
A
G
1
3
M
31
50
Ta
g1
3-
ap
hT
Sm
,K
m
SB
30
0T
A
G
1
7
M
31
51
Ta
g1
7-
ap
hT
Sm
,K
m
SB
30
0T
A
G
1
9
M
31
52
Ta
g1
9-
ap
hT
Sm
,K
m
SB
30
0T
A
G
2
1
M
31
53
Ta
g2
1-
ap
hT
Sm
,K
m
S.
Tm
Δ
4
M
56
6
Δ
si
pA
so
pB
so
pE
so
pE
2
IE
C
in
va
si
o
n
-d
efi
ci
en
t
m
u
ta
n
t
Sm
7
1
S.
Tm
Δ
4
TA
G
1
Z
25
57
Δ
si
pA
so
pB
so
pE
so
pE
2,
Ta
g1
-a
ph
T
C
o
lle
ct
iv
el
y
re
fe
rr
ed
to
as
W
IT
SΔ
4
Sm
,K
m
Th
is
st
u
d
y
S.
Tm
Δ
4
TA
G
2
Z
25
58
Δ
si
pA
so
pB
so
pE
so
pE
2,
Ta
g2
-a
ph
T
Sm
,K
m
Th
is
st
u
d
y
S.
Tm
Δ
4
TA
G
1
1
Z
25
59
Δ
si
pA
so
pB
so
pE
so
pE
2,
Ta
g1
1-
ap
hT
Sm
,K
m
Th
is
st
u
d
y
S.
Tm
Δ
4
TA
G
1
3
Z
25
60
Δ
si
pA
so
pB
so
pE
so
pE
2,
Ta
g1
3-
ap
hT
Sm
,K
m
Th
is
st
u
d
y
S.
Tm
Δ
4
TA
G
1
7
Z
25
61
Δ
si
pA
so
pB
so
pE
so
pE
2,
Ta
g1
7-
ap
hT
Sm
,K
m
Th
is
st
u
d
y
S.
Tm
Δ
4
TA
G
1
9
Z
25
62
Δ
si
pA
so
pB
so
pE
so
pE
2,
Ta
g1
9-
ap
hT
Sm
,K
m
Th
is
st
u
d
y
S.
Tm
Δ
4
TA
G
2
1
Z
25
63
Δ
si
pA
so
pB
so
pE
so
pE
2,
Ta
g2
1-
ap
hT
Sm
,K
m
Th
is
st
u
d
y
S.
Tm
S
P
I-
2
-G
F
P
SB
30
0
p
ss
aG
-G
FP
m
ut
2
p
ss
aG
-G
FP
m
ut
2
(p
M
97
5)
:e
xp
re
ss
io
n
o
f
G
FP
m
u
t2
u
n
d
er
ss
aG
(S
PI
-2
)
p
ro
m
o
to
r,
w
h
ic
h
is
ac
ti
ve
in
si
d
e
th
e
SC
V
(S
.T
m
S
P
I-
2
)
Sm
,A
m
p
7
2
S.
Tm
S
P
I-
1
-G
F
P
Z
14
04
pr
gH
-G
FP
SP
I-1
re
g
u
la
te
d
ex
p
re
ss
io
n
o
f
G
FP
(S
.T
m
S
P
I-
1
)
Sm
,C
m
1
0
7
S.
Tm
lo
ca
liz
e
r
Z
14
40
ss
aG
-G
FP
p
uh
pT
-m
Ch
er
ry
p
uh
pT
-m
Ch
er
ry
(p
C
K
10
0/
p
Z
14
00
):
G
lc
6P
in
d
u
ce
d
m
C
h
er
ry
ex
p
re
ss
io
n
as
a
re
p
o
rt
er
fo
r
cy
to
so
lic
lo
ca
liz
at
io
n
(S
.T
m
G
lc
6
P
).
In
ad
d
it
io
n
,t
h
is
st
ra
in
co
n
ta
in
s
an
ss
aG
-d
ri
ve
n
G
FP
re
p
o
rt
er
fo
r
SC
V
lo
ca
liz
at
io
n
(S
.T
m
S
P
I-
2
)
Sm
,A
m
p
,C
m
Th
is
st
u
d
y
S.
Tm
G
lc
6
p
-m
C
h
e
rr
y
Z
14
39
p
uh
pT
-m
Ch
er
ry
p
uh
pT
-m
Ch
er
ry
(p
C
K
10
0/
p
Z
14
00
):
G
lc
6P
in
d
u
ce
d
m
C
h
er
ry
ex
p
re
ss
io
n
as
a
re
p
o
rt
er
fo
r
cy
to
so
lic
lo
ca
liz
at
io
n
(S
.T
m
G
lc
6
P
).
Sm
,A
m
p
Th
is
st
u
d
y
S.
Tm
Δ
fl
iG
H
I
M
91
3
Δ
fl
iG
H
I
p
ss
aG
-G
FP
m
ut
2
Fl
ag
el
la
-d
efi
ci
en
t
m
u
ta
n
t.
A
ls
o
co
n
ta
in
s
p
ss
aG
-G
FP
m
ut
2
(p
M
97
5)
:e
xp
re
ss
io
n
o
f
G
FP
m
u
t2
u
n
d
er
ss
aG
(S
PI
-2
)
p
ro
m
o
to
r,
w
h
ic
h
is
ac
ti
ve
in
si
d
e
th
e
SC
V
(S
.T
m
S
P
I-
2
)
Sm
,A
m
p
,T
et
1
0
8
S.
Tm
fl
iC
in
d
Z
25
00
Δ
fl
gB
,T
ag
1-
ap
hT
p
EM
08
7
Fl
ag
el
la
-d
efi
ci
en
t
m
u
ta
n
t.
A
ls
o
co
n
ta
in
s
p
EM
08
7:
D
o
xy
cy
cl
in
e
in
d
u
ci
b
le
ex
p
re
ss
io
n
o
f
Fl
iC
Sm
,C
m
,
A
m
p
,
Te
t,
K
m
1
4
S.
Tm
E
C
V
Z
25
30
Δ
fl
gB
,T
ag
13
-a
ph
T
p
Z
25
00
Fl
ag
el
la
-d
efi
ci
en
t
m
u
ta
n
t.
A
ls
o
co
n
ta
in
s
p
Z
25
00
:E
m
p
ty
co
n
tr
o
l
ve
ct
o
r
fo
r
p
EM
08
7
ca
rr
yi
n
g
a
Te
t
(D
o
xy
cy
cl
in
e)
re
si
st
an
ce
ca
ss
et
te
Sm
,C
m
,
A
m
p
,
Te
t,
K
m
1
4
14
02
8
M
31
68
Ip
fE
D
::a
ph
T
R
ef
er
re
d
to
as
S.
Tm
1
4
0
2
8
K
m
9
7
14
02
8T
A
G
1
Z
67
08
Ip
fE
D
::a
ph
T,
Ta
g1
-c
at
C
o
lle
ct
iv
el
y
re
fe
rr
ed
to
as
W
IT
S1
4
0
2
8
K
m
,C
m
Th
is
st
u
d
y
14
02
8T
A
G
2
Z
67
09
Ip
fE
D
::a
ph
T,
Ta
g2
-c
at
K
m
,C
m
Th
is
st
u
d
y
14
02
8T
A
G
1
1
Z
67
10
Ip
fE
D
::a
ph
T,
Ta
g1
1-
ca
t
K
m
,C
m
Th
is
st
u
d
y
14
02
8T
A
G
1
3
Z
67
11
Ip
fE
D
::a
ph
T,
Ta
g1
3-
ca
t
K
m
,C
m
Th
is
st
u
d
y
14
02
8T
A
G
1
7
Z
67
12
Ip
fE
D
::a
ph
T,
Ta
g1
7-
ca
t
K
m
,C
m
Th
is
st
u
d
y
14
02
8T
A
G
1
9
Z
67
13
Ip
fE
D
::a
ph
T,
Ta
g1
9-
ca
t
K
m
,C
m
Th
is
st
u
d
y
14
02
8T
A
G
2
1
Z
67
14
Ip
fE
D
::a
ph
T,
Ta
g2
1-
ca
t
K
m
,C
m
Th
is
st
u
d
y
Sm
=
St
re
p
to
m
yc
in
.
K
m
=
K
an
am
yc
in
.C
m
=
C
h
lo
ra
m
p
h
en
ic
o
l.
A
m
p
=
A
m
p
ic
ill
in
.
Te
t=
Te
tr
ac
yc
lin
e.
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the. . .
A Hausmann et al.
540
Mucosal Immunology (2020) 13:530 – 544
was generated by electroporation of the plasmid pEM08714 into S.
Tm.ΔflgB S. TmΔflgB carrying an empty control plasmid was used as
“wildtype” control in the respective experiment (S. Tm,ECV Fig S7).
Genetic barcodes were introduced by P22 phage transduction into
S. TmfliCind and S. TmECV for relative quantification of the
abundance of the two strains during competitive infection. See
Table 1 for further information. For oral and HeLa cell infections,
S. Tm was grown overnight at 37 °C in LB/0.3M NaCl and
sucultured for four hours at a dilution of 1:20. For iv infections,
S. Tm was grown overnight in LB/0.3M NaCl.
Tissue culture and infections
HeLa CCL-2 cells (ATCC) were grown in DMEM (Gibco) supple-
mented with 10% inactivated FCS (Thermo Fischer) and 50 μg/mL
Streptomycin (AppliChem) at 37 °C and 5% CO2. For immuno-
fluorescence experiments, 80.000 HeLa cells were seeded in 24-
well plates (Nunc, Thermo Fisher) containing glass cover slips 24 h
prior to infection. Cells were infected with S. TmSPI-2-GFP at an
estimated MOI of 300, S. Tmlocalizer at an estimated MOI of 300, and
S. TmΔfliGHI (pssaG-GFPmut2) at an estimated MOI of 1000 for 14
mpi, 1 hpi, 3 hpi, 5 hpi, and 7 hpi (S. Tm,SPI-2-GFP S. Tmlocalizer) and
14 mpi and 1 hpi (S. TmΔfliGHI(pssaG-GFPmut2)). After 20 min,
infected HeLa cells were washed three times with DMEM/10% FCS
and incubated with DMEM/10% FCS containing 400 μg/mL
Gentamicin to prevent further infection. For electron microscopy
(EM) imaging experiments, EM finder grids (gold NH2 R2/2,
Quantifoil) were sterilized under UV light and then glow
discharged. Grids were placed on the bottom of the wells of a
12-well plate (Nunc, Thermo Fisher) and equilibrated with DMEM
for 30 min. Subsequently, 30,000 HeLa cells were seeded into each
well (containing one grid each) and incubated overnight. Cells
were infected with S. TmSPI-2-GFP at an estimated MOI of 300 for 1 h
as described above. Grids were washed twice with HBSS before
vitrification.
Mice and infections
All studies were performed in accordance with ethical and legal
requirements and were approved by the Kantonales Veterinäramt
Zürich under the licenses 222/2013 and 193/2016. Mice were kept
under specific pathogen-free conditions in individually ventilated
cages (EPIC and RCHCI, ETH Zürich). All knockout mouse lines
presented here have a C57BL/6 background, Naip1-6,−/− Naip1-
6ΔIEC, and Naip1-6ΔCD11c have a C57BL/6J background, Nlrc4−/−
mice a C57BL/6NJ background. S. Tm infections were performed
as described before56 on 8–12 week old mice. Cohoused,
heterozygous littermates were used as controls in all infections.
Control mice for Fig. 8B were supplemented with unrelated wild
type mice (Nlrc4+/+). For oral infection, mice were pretreated
orally with 25 mg Streptomycin or 10 mg Kanamycin (for S.
Tm14028) 24 h prior to infection. Infection was performed by
intragastrical inoculation with 5 × 107 bacteria in 50 µl PBS. For
WITS infections, the WITS strains (Kanamycin resistant) were
diluted 1:140 (for wildtype S. Tm) or 1:21 (for S. TmΔ4) in the
respective untagged S. Tm strain. For iv infection, 104 S. Tm in 100
µl PBS were injected into the tail vein. For WITS iv infections, WITS
strains (Kanamycin resistant) were diluted 1:700 in untagged
wildtype S. Tm. The infection with S. TmfliCind was performed by iv
injection of 104 CFU in a 1:1 mix of S. TmfliCind and S. Tm.ECV Both
strains showed equal growth in vitro (data not shown). At 17 hpi,
0.8 mg Doxycycline in 100 µl PBS was administered iv for
induction of FliC expression. At 24 hpi, mice were euthanized
and organs and cecal content were collected, homogenized, and
plated on MacConkey Agar (Oxoid) containing the respective
antibiotics for enumeration of bacterial counts in the respective
tissue. For competitive infections, relative abundance of the two
competitors in the tissue of interest was assessed by quantitative
real-time PCR (qPCR) with the help of neutral genetic tags as
described below.
LPS injections and sorting of intestinal DCs
Mice were iv injected with 5 μg ultrapure S. Tm LPS (Otto Holst) in
100 μl PBS, or 100 μl PBS as control. One hour post injection, mice
were euthanized and cecae were excised. Cecum tissue was
washed extensively with PBS, cut into small pieces and incubated
twice for 20 min at 37 °C shaking in 13 ml PBS supplemented with
5 mM EDTA (Life Technologies), 15 mM HEPES (Life Technologies)
and 10% heat-inactivated FBS (Life Technologies). Tissue pieces
were washed in 7 ml RPMI 1640 (Life Technologies)/30% FBS and
subsequently incubated for 1 h at 37 °C shaking in 900 μl RPMI
containing 0.2 mg/ml DNase I (Roche) and 1mg/ml collagenase
VIII (Sigma). Digested material was mashed through a 70 μm cell
strainer and washed with 10 ml RPMI. After washing, cells were
resuspended in 6ml RPMI, carefully loaded onto 3ml NycoPrep
1.077 and centrifuged for 30 min at 400 × g (room temperature).
The interphase fraction was collected (~2 ml), washed in 6 ml RPMI
containing 15% FBS, and subsequently stained for fluorescent
activated cell sorting (FACS). Cells from three mice were pooled
per sample for sorting. The following antibodies were used for
staining of intestinal DCs: CD45-PerCP (Biolegend, 30-F11, 1:100),
MHCII-APC (Biolegend, M5/114.15.2, 1:400), CD103-PE (Biolegend,
2E7, 1:100), CD11b-BV605 (Biolegend, M1/70, 1:200), CD11c-PE/
Cy7 (Biolegend, N418, 1:200), Sytox-blue (Invitrogen, 1:1000).
Intestinal DCs were sorted for CD45+MHCIIhi CD11chi live cells and
differentiated into CD103+ CD11b,− CD103− CD11b,+ CD103+
CD11b+, and CD103− CD11b− populations. Cells were FACS
sorted with a BD FACSAria III sorter into 50 μl RNAlater (Sigma) and
flash frozen in liquid nitrogen.
WITS quantification
WITS-tagged S. Tm from mLN (oral infection) or spleen (iv
infection) homogenate were specifically enriched in 3 ml LB
supplemented with 50 µg/ml Kanamycin overnight. Bacterial DNA
was isolated from enrichment cultures (Qiagen QIAamp DNA Mini
Kit) and subsequently analyzed on a StepOne Plus Cycler (Thermo
Fisher), using FastStart Universal SYBR Green Master (Rox)
reagents (Roche) and primers as described before.58 Total
abundance of the WITS strains was assessed by integrating their
relative distribution analyzed by qPCR with total bacterial CFU
obtained through plating.
Population dynamics analysis
Population dynamics were analyzed with a previously published
model,59 based on total WITS counts in the organ of interest of
each mouse. This method was developed for the estimation of the
migration rate µ from the gut lumen to the mLN and the
replication rate r within the mLN during oral S. Tm infection, and
was directly used for the estimates of the oral infection
experiments (Figs. 1–3, S5). We applied the same method to
estimate the migration rate µ from the blood to and the
replication rate r within the spleen for the iv infection experiments
(Fig. 4). We note that the interpretation of the migration rate
estimate for this application of the model differs from the original
application. The migration is assumed to be constant over time in
the model, however, previous research has shown that the
number of bacteria in the blood exponentially decreases for iv
inoculation.99 Therefore, the migration we estimate to occur with
a constant rate over one day, might have migrated only within the
first few hours after inoculation. However, because we are not
primarily interested in the migration rates themselves but
rather the differences in migration rates between wildtype and
knockout mice, this interpretational subtlety does not confound
our conclusions. Calculations were performed with R Studio,
R version 3.6.0.
Gene expression analysis
For gene expression analysis, tissue was snap frozen in RNAlater
(Sigma-Aldrich). RNA isolation was performed with the Qiagen
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RNeasy Mini Kit according to the manufacturer's instructions,
including DNase digestion. For sorted intestinal DCs, RNA isolation
was performed with the Qiagen RNeasy Micro Kit after cell lysis
with the QIAShredder Kit (Qiagen) according to the manufac-
turer`s instructions. One microgram of isolated RNA was subse-
quently transcribed into cDNA using the Qiagen RT2 HT First
Strand cDNA Kit, and stored at −20 °C until analysis. qPCR was
performed with FastStart Universal SYBR Green Master (Rox)
reagents (Roche) on a StepOne Plus Cycler (Thermo Fischer).
mRNA levels were normalized to Actb and calculated with the
2−ΔCT-method. Primers for the indicated genes were purchased
from Qiagen (RT2 qPCR Primer Assay).
Histopathology
For the assessment of histopathology, cecal tissue was snap-
frozen in OCT (Tissue-Tek) and stored at −80 °C. Five micrometer
sections were cut from the tissue and stained with hematoxylin
and eosin as described before.56 Tissue pathology was scored
according to the extent of submucosal edema, epithelial integrity,
goblet cell loss and infiltration of polymorphonuclear neutrophils
(PMNs) into the lamina propria.
Fluorescence microscopy
Infected HeLa cells were fixed with 4% Paraformaldehyde (Sigma-
Aldrich) for 15 min (room temperature) and subsequently
permeabilized with 0.1% Triton X-100 for 5 min (room tempera-
ture). Afterwards cells were washed twice with 4% sucrose and
incubated in 20% sucrose for 20 min. Next, cells were incubated
with blocking buffer for 1 h (3% bovine serum albumin, BSA; 3%
sucrose in DPBS) before staining with the respective primary
antibodies (rabbit-αLPS, DifcoTM Salmonella O Antiserum, 1:200;
mouse-αFliC, Abcam, 1:300) for 1 h. After three washes with PBS
samples were incubated with secondary antibodies (goat-αmouse
IgG Cy5; goat-αrabbit IgG Alexa Fluor 405; 1:600, Thermo Fischer)
for 1h. Finally, samples were washed three times with PBS and
mounted on microscope slides with 5 μl Mowiol. For immuno-
fluorescence staining of infected organs, cecal tissue and spleens
of infected mice were fixed in 4% Paraformaldehyde (Sigma-
Aldrich) for 4 h at 4 °C, dehydrated in 20% sucrose for 4 h at 4 °C,
embedded in OCT (Tissue-Tek), flash frozen and stored at −80 °C.
For detection of flagellated intracellular S. Tm, 20 µm sections of
cecal mucosa and spleen were prepared. After rehydration (PBS,
1 min), sections were permeabilized with 0.5% Triton X-100 for
5 min (room temperature). Next, samples were incubated in
blocking buffer (10% normal goat serum, Reactolab) for 30 min.
Sections from JH−/− mice were stained for 40 min (room
temperature) using a mouse-αFliC antibody (Abcam, 1:300).
Sections from Naip1-6Δ/ΔIEC knockout mice were incubated with
a FliC-Cy3-conjugated antibody (1:300; Cy3® Fast Conjugation Kit
Abcam; ab188287). After three washes with PBS, samples were
stained for 40 min (αmouse IgG-Cy3, 1:200; Phalloidin-A647, 1:200;
DAPI, 1:1000; Thermo Fischer). Finally, samples were washed three
times with PBS and a coverslip was mounted on the microscope
slide with 15 μL Mowiol. Image acquisition was performed with a
Nikon Eclipse T1 (inverse) microscope equipped with a Yokogawa
CSU-W1-T2 spinning-disk confocal unit (Visitron), a sCMOS camera
(Orca Flash 4.0 V2) and a ×100 oil objective (PLAN Apochromat,
NA 1.49). All data were analyzed in Fiji.100
Preparation of frozen-hydrated specimens
Plunge freezing was performed as previously described.101 Briefly,
grids containing infected HeLa cells, were removed from the wells
using tweezers. The forceps were then mounted in the Vitrobot
chamber and the grid was blotted from the backside by installing
a Teflon sheet on one of the blotting pads. Grids were plunge-
frozen in liquid ethane-propane (37%/63%) using a Vitrobot
(Thermo Fisher) and stored in liquid nitrogen.102
Cryo-focused ion beam milling
Cryo-focused ion beam (cryoFIB) milling was used to prepare
samples of plunge-frozen infected HeLa cells that could then be
imaged by cryo-electron tomography.103 Frozen grids with
infected HeLa cells were prepared and processed as previously
described.102 Briefly, lamellae were milled in several steps in a
Helios NanoLab600i dual beam FIB/SEM instrument (Thermo
Fisher). In a first step, two rectangular regions were used to
generate a lamella with ~2 µm thickness with the ion beam set to
30 kV and ~400 pA. The current of the ion beam was then
gradually reduced until the lamella reached a nominal thickness of
~250 nm (ion beam set to ~25 pA). The stage temperature was
maintained below −154 °C during loading, milling and unloading
procedures. CryoFIB-processed grids were unloaded and stored in
liquid nitrogen until further use.
Cryo-electron microscopy and cryo-electron tomography
CryoFIB processed infected HeLa cells were examined by cryo-
electron microscopy (cryoEM) and cryo-electron tomography
(cryoET).101,102 Images were recorded on a Titan Krios TEM
(Thermo Fisher) equipped with a Quantum LS imaging filter and
K2 Summit (Gatan). The microscope was operated at 300kV and
the imaging filter was set to a 20 eV slit width. The pixel size at the
specimen level was 5.42 Å. Tilt series covered an angular range
from −60° to +60° with 2° increments and −8 µm defocus. The
total dose of a tilt series was 120 e−/Å.2 Tilt series and 2D
projection images were acquired automatically using SerialEM.104
Three-dimensional reconstructions and segmentations were
generated using the IMOD program suite.105
ACKNOWLEDGEMENTS
We are thankful to the members of the Hardt, Sellin, Slack, and Pilhofer labs for
discussions and input, and to the staff of the RCHCI and EPIC animal facilities for their
support. We would like to thank Edward Miao at the Department of Microbiology and
Immunology, University of Carolina, USA for providing the pEM087 plasmid and Otto
Holst at the Division of Structural Biochemistry at the Research Center Borstel,
Germany for providing ultrapure LPS. W.D.H. was supported by the Swiss National
Science Foundation (SNF) (310030_53074 and 310030B_173338/1; Sinergia
CRSII_154414/1), and the Promedica Foundation, Chur. M.E.S. was supported by
the Swedish Research Council (2015-00635, 2018-02223) and the Swedish Founda-
tion for Strategical Research (ICA16-0031). M.P. was supported by the SNF (164092),
and the European Research Council (679209). R.R.R. acknowledges financial support
from SNF (31003A_179170). E.S. acknowledges funding from Gebert Rüf Microbials
GRS17_93, and the SNF (310030_185128 and 20B2-1_180953). I.K. was funded by a
postdoctoral Research Fellowship of the Deutsche Forschungsgemeinschaft. E.B. was
funded by an Boerhinger Ingelheim PhD Fellowship.
AUTHOR CONTRIBUTIONS
A.H. (Figs. 1–5, 6B–G, S2, S3, S5, S6, S8, S9), D.Bö. (Fig. 6, S7-S8A), P.G. (Figs. 1–3,
S2A-C, S3A-C), D.L.B. (Fig. S6C, S9), S.A.F. (Fig. S4) and M.F. (Fig. S8B) performed
experiments and analyzed data. D.Bö. (Fig. 6a) established and performed cryo-
FIBmilling/cryoET. J.B. and R.R.R. (Fig. 4) performed mathematical modeling. M.B.S.,
C.M.L., I.K. provided technical assistance. M.F., E.B., D.B., M.D. provided bacterial
strains. A.H., D.Bö., E.S., M.P., M.E.S., and W.D.H. designed experiments. A.H., M.E.S.,
and W.D.H. devised the project and wrote the paper. All authors read, amended,
and approved the paper.
ADDITIONAL INFORMATION
The online version of this article (https://doi.org/10.1038/s41385-019-0247-0)
contains supplementary material, which is available to authorized users.
Competing interests: The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional affiliations.
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the. . .
A Hausmann et al.
542
Mucosal Immunology (2020) 13:530 – 544
REFERENCES
1. Hausmann, A. & Hardt, W.-D. The interplay between Salmonella enterica Serovar
Typhimurium and the intestinal mucosa during oral infection. Microbiol. Spectr.
7, 41–58 (2019).
2. Birchenough, G. M. H., Nyström, E. E. L., Johansson, M. E. V. & Hansson, G. C. A
sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent
Muc2 secretion. Science 352, 1535–1542 (2016).
3. Brandl, K., Plitas, G., Schnabl, B., DeMatteo, R. P. & Pamer, E. G. MyD88-mediated
signals induce the bactericidal lectin RegIII gamma and protect mice against
intestinal Listeria monocytogenes infection. J. Exp. Med. 204, 1891–1900 (2007).
4. Furter, M., Sellin, M. E., Hansson, G. C. & Hardt, W.-D. Mucus architecture and
near-surface swimming affect distinct Salmonella Typhimurium infection pat-
terns along the murine intestinal tract. Cell Rep. 27, 2665–2678.e3 (2019).
5. Johansson, M. E. V. & Hansson, G. C. Immunological aspects of intestinal mucus
and mucins. Nat. Rev. Immunol. 16, 639–649 (2016).
6. Miki, T. & Hardt, W.-D. Outer membrane permeabilization is an essential step in
the killing of gram-negative bacteria by the lectin RegIIIβ. PloS One 8, e69901
(2013).
7. Ostaff, M. J., Stange, E. F. & Wehkamp, J. Antimicrobial peptides and gut
microbiota in homeostasis and pathology. EMBO Mol. Med. 5, 1465–1483 (2013).
8. Franchi, L. et al. NLRC4-driven production of IL-1β discriminates between
pathogenic and commensal bacteria and promotes host intestinal defense. Nat.
Immunol. 13, 449–456 (2012).
9. Kinnebrew, M. A. et al. Interleukin 23 production by intestinal CD103(+)CD11b
(+) dendritic cells in response to bacterial flagellin enhances mucosal innate
immune defense. Immunity 36, 276–287 (2012).
10. Rauch, I. et al. NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell
expulsion with eicosanoid and IL-18 release via activation of caspase-1 and -8.
Immunity 46, 649–659 (2017).
11. Sellin, M. E. et al. Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected
enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa.
Cell Host Microbe 16, 237–248 (2014).
12. Conlan, J. W. Critical roles of neutrophils in host defense against experimental
systemic infections of mice by Listeria monocytogenes, Salmonella typhimur-
ium, and Yersinia enterocolitica. Infect. Immun. 65, 630–635 (1997).
13. Felmy, B. et al. NADPH oxidase deficient mice develop colitis and bacteremia
upon infection with normally avirulent, TTSS-1- and TTSS-2-deficient Salmonella
Typhimurium. PloS One 8, e77204 (2013).
14. Jorgensen, I., Zhang, Y., Krantz, B. A. & Miao, E. A. Pyroptosis triggers pore-
induced intracellular traps (PITs) that capture bacteria and lead to their clear-
ance by efferocytosis. J. Exp. Med. 213, 2113–2128 (2016).
15. Nathan, C. & Shiloh, M. U. Reactive oxygen and nitrogen intermediates in the
relationship between mammalian hosts and microbial pathogens. Proc. Natl
Acad. Sci. USA 97, 8841–8848 (2000).
16. Stecher, B. et al. Motility allows S. Typhimurium to benefit from the mucosal
defence. Cell. Microbiol. 10, 1166–1180 (2008).
17. Galán, J. E. & Curtiss, R. Cloning and molecular characterization of genes whose
products allow Salmonella typhimurium to penetrate tissue culture cells. Proc.
Natl Acad. Sci. USA 86, 6383–6387 (1989).
18. Müller, A. J. et al. Salmonella gut invasion involves TTSS-2-dependent epithelial
traversal, basolateral exit, and uptake by epithelium-sampling lamina propria
phagocytes. Cell Host Microbe 11, 19–32 (2012).
19. Hapfelmeier, S. et al. Microbe sampling by mucosal dendritic cells is a discrete,
MyD88-independent step in DeltainvG S. Typhimurium colitis. J. Exp. Med. 205,
437–450 (2008).
20. Niess, J. H. et al. CX3CR1-mediated dendritic cell access to the intestinal lumen
and bacterial clearance. Science 307, 254–258 (2005).
21. Rescigno, M. et al. Dendritic cells express tight junction proteins and penetrate
gut epithelial monolayers to sample bacteria. Nat. Immunol. 2, 361–367 (2001).
22. Diehl, G. E. et al. Microbiota restricts trafficking of bacteria to mesenteric lymph
nodes by CX(3)CR1(hi) cells. Nature 494, 116–120 (2013).
23. Bravo-Blas, A. et al. Salmonella enterica Serovar Typhimurium travels to
mesenteric lymph nodes both with host cells and autonomously. J. Immunol.
202, 260–267 (2019).
24. Bastedo, D. P., Lo, T., Laflamme, B., Desveaux, D. & Guttman, D. S. Diversity and
evolution of Type III secreted effectors: a case study of three families. Curr. Top.
Microbiol. Immunol. https://doi.org/10.1007/82_2019_165 (2019).
25. Brewer, S. M., Brubaker, S. W. & Monack, D. M. Host inflammasome defense
mechanisms and bacterial pathogen evasion strategies. Curr. Opin. Immunol. 60,
63–70 (2019).
26. Broz, P. Recognition of intracellular bacteria by inflammasomes. Microbiol.
Spectr. 7, 287–298 (2019).
27. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform
triggering activation of inflammatory caspases and processing of proIL-beta.
Mol. Cell 10, 417–426 (2002).
28. Moltke, Jvon et al. Rapid induction of inflammatory lipid mediators by the
inflammasome in vivo. Nature 490, 107–111 (2012).
29. Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyr-
optotic cell death. Nature 526, 660–665 (2015).
30. Miao, E. A. & Warren, S. E. Innate immune detection of bacterial virulence factors
via the NLRC4 inflammasome. J. Clin. Immunol. 30, 502–506 (2010).
31. Müller, A. A. et al. An NK cell perforin response elicited via IL-18 controls
mucosal inflammation kinetics during salmonella gut infection. PLoS Pathog. 12,
e1005723 (2016).
32. Kofoed, E. M. & Vance, R. E. Innate immune recognition of bacterial ligands by
NAIPs determines inflammasome specificity. Nature 477, 592–595 (2011).
33. Rauch, I. et al. NAIP proteins are required for cytosolic detection of specific
bacterial ligands in vivo. J. Exp. Med. 213, 657–665 (2016).
34. Rayamajhi, M., Zak, D. E., Chavarria-Smith, J., Vance, R. E. & Miao, E. A. Cutting
edge: mouse NAIP1 detects the type III secretion system needle protein.
J. Immunol. 191, 3986–3989 (2013).
35. Yang, J., Zhao, Y., Shi, J. & Shao, F. Human NAIP and mouse NAIP1 recognize
bacterial type III secretion needle protein for inflammasome activation. Proc.
Natl Acad. Sci. USA 110, 14408–14413 (2013).
36. Zhao, Y. et al. The NLRC4 inflammasome receptors for bacterial flagellin and
type III secretion apparatus. Nature 477, 596–600 (2011).
37. Broz, P. et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in
host defense against Salmonella. J. Exp. Med. 207, 1745–1755 (2010).
38. Diamond, C. E. et al. Salmonella typhimurium-induced IL-1 release from primary
human monocytes requires NLRP3 and can occur in the absence of pyroptosis.
Sci. Rep. 7, 6861 (2017).
39. Man, S. M. et al. Inflammasome activation causes dual recruitment of NLRC4 and
NLRP3 to the same macromolecular complex. Proc. Natl Acad. Sci. USA 111,
7403–7408 (2014).
40. Aachoui, Y. et al. Caspase-11 protects against bacteria that escape the vacuole.
Science 339, 975–978 (2013).
41. Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11.
Nature 479, 117–121 (2011).
42. Thurston, T. L. M. et al. Growth inhibition of cytosolic Salmonella by caspase-1
and caspase-11 precedes host cell death. Nat. Commun. 7, 13292 (2016).
43. Knodler, L. A. et al. Noncanonical inflammasome activation of caspase-4/cas-
pase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell
Host Microbe 16, 249–256 (2014).
44. Lara-Tejero, M. et al. Role of the caspase-1 inflammasome in Salmonella typhi-
murium pathogenesis. J. Exp. Med. 203, 1407–1412 (2006).
45. Monack, D. M. et al. Salmonella exploits caspase-1 to colonize Peyer’s patches in
a murine typhoid model. J. Exp. Med. 192, 249–258 (2000).
46. Raupach, B., Peuschel, S.-K., Monack, D. M. & Zychlinsky, A. Caspase-1-Mediated
Activation of Interleukin-1β (IL-1β) and IL-18 Contributes to Innate Immune
Defenses against Salmonella enterica Serovar Typhimurium Infection. Infect.
Immun. 74, 4922–4926 (2006).
47. Carvalho, F. A. et al. Cytosolic flagellin receptor NLRC4 protects mice against
mucosal and systemic challenges. Mucosal Immunol. 5, 288–298 (2012).
48. Franchi, L. et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and
interleukin 1β in salmonella-infected macrophages. Nat. Immunol. 7, 576–582
(2006).
49. De Jong, H. K. et al. Limited role for ASC and NLRP3 during in vivo Salmonella
Typhimurium infection. BMC Immunol. 15, 30 (2014).
50. Broz, P. et al. Caspase-11 increases susceptibility to Salmonella infection in the
absence of caspase-1. Nature 490, 288–291 (2012).
51. Mamantopoulos, M. et al. Nlrp6- and ASC-dependent inflammasomes do not
shape the commensal gut microbiota composition. Immunity 47, 339–348.e4
(2017).
52. Mamantopoulos, M., Ronchi, F., McCoy, K. D. & Wullaert, A. Inflammasomes make
the case for littermate-controlled experimental design in studying host-
microbiota interactions. Gut Microbes 9, 374–381 (2018).
53. Robertson, S. J. et al. Comparison of co-housing and littermate methods for
microbiota standardization in mouse models. Cell Rep. 27, 1910–1919.e2 (2019).
54. Wullaert, A., Lamkanfi, M. & McCoy, K. D. Defining the impact of host genotypes
on microbiota composition requires meticulous control of experimental vari-
ables. Immunity 48, 605–607 (2018).
55. Nordlander, S., Pott, J. & Maloy, K. J. NLRC4 expression in intestinal epithelial
cells mediates protection against an enteric pathogen. Mucosal Immunol. 7,
775–785 (2014).
56. Barthel, M. et al. Pretreatment of mice with Streptomycin provides a Salmonella
enterica Serovar Typhimurium colitis model that allows analysis of both
pathogen and host. Infect. Immun. 71, 2839–2858 (2003).
57. Kaiser, P. & Hardt, W.-D. Salmonella typhimurium diarrhea: switching the
mucosal epithelium from homeostasis to defense. Curr. Opin. Immunol. 23,
456–463 (2011).
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the. . .
A Hausmann et al.
543
Mucosal Immunology (2020) 13:530 – 544
58. Grant, A. J. et al. Modelling within-host spatiotemporal dynamics of invasive
bacterial disease. PLoS Biol. 6, e74 (2008).
59. Kaiser, P., Slack, E., Grant, A. J., Hardt, W.-D. & Regoes, R. R. Lymph node colo-
nization dynamics after oral Salmonella Typhimurium infection in mice. PLoS
Pathog. 9, e1003532 (2013).
60. Kaiser, P., Regoes, R. R. & Hardt, W.-D. Population dynamics analysis of
ciprofloxacin-persistent S. Typhimurium cells in a mouse model for Salmonella
Diarrhea. Methods Mol. Biol. 1333, 189–203 (2016).
61. Maier, L. et al. Granulocytes impose a tight bottleneck upon the gut luminal
pathogen population during Salmonella typhimurium colitis. PLoS Pathog. 10,
e1004557 (2014).
62. Mastroeni, P. & Grant, A. Dynamics of spread of Salmonella enterica in the
systemic compartment. Microbes Infect. 15, 849–857 (2013).
63. Moor, K. et al. High-avidity IgA protects the intestine by enchaining growing
bacteria. Nature 544, 498–502 (2017).
64. Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1
adaptors ASC and Ipaf. Nature 430, 213–218 (2004).
65. Stecher, B. et al. Salmonella enterica serovar typhimurium exploits inflammation
to compete with the intestinal microbiota. PLoS Biol. 5, 2177–2189 (2007).
66. Allam, R. et al. Epithelial NAIPs protect against colonic tumorigenesis. J. Exp.
Med. 212, 369–383 (2015).
67. Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric
acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).
68. Li, P. et al. Mice deficient in IL-1 beta-converting enzyme are defective in production
of mature IL-1 beta and resistant to endotoxic shock. Cell 80, 401–411 (1995).
69. Mascarenhas, D. P. A. et al. Inhibition of caspase-1 or gasdermin-D enable
caspase-8 activation in the Naip5/NLRC4/ASC inflammasome. PLoS Pathog. 13,
e1006502 (2017).
70. Van Opdenbosch, N. et al. Caspase-1 engagement and TLR-induced c-FLIP
expression suppress ASC/Caspase-8-dependent apoptosis by inflammasome
sensors NLRP1b and NLRC4. Cell Rep. 21, 3427–3444 (2017).
71. Ehrbar, K., Friebel, A., Miller, S. I. & Hardt, W.-D. Role of the Salmonella patho-
genicity island 1 (SPI-1) protein InvB in type III secretion of SopE and SopE2, two
Salmonella effector proteins encoded outside of SPI-1. J. Bacteriol. 185,
6950–6967 (2003).
72. Hapfelmeier, S. et al. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type
III secretion systems allow Salmonella serovar typhimurium to trigger colitis via
MyD88-dependent and MyD88-independent mechanisms. J. Immunol. 174,
1675–1685 (2005).
73. Müller, A. J. et al. The S. Typhimurium effector SopE induces caspase-1 activation
in stromal cells to initiate gut inflammation. Cell Host Microbe 6, 125–136 (2009).
74. Misselwitz, B. et al. Salmonella enterica Serovar Typhimurium Binds to HeLa cells
via fim-mediated reversible adhesion and irreversible type three secretion sys-
tem 1-mediated docking. Infect. Immun. 79, 330–341 (2011).
75. Sheppard, M. et al. Dynamics of bacterial growth and distribution within the
liver during Salmonella infection. Cell. Microbiol. 5, 593–600 (2003).
76. Man, S. M. et al. Differential roles of caspase-1 and caspase-11 in infection and
inflammation. Sci. Rep. 7, 45126 (2017).
77. Winsor, N., Krustev, C., Bruce, J., Philpott, D. J. & Girardin, S. E. Canonical and non-
canonical inflammasomes in intestinal epithelial cells. Cell. Microbiol. e13079 (2019).
78. Tomalka, J. et al. A novel role for the NLRC4 inflammasome in mucosal defenses
against the fungal pathogen Candida albicans. PLoS Pathog. 7, e1002379 (2011).
79. Stagg, A. J. Intestinal dendritic cells in health and gut inflammation. Front.
Immunol. 9, 1–10 (2018).
80. Hong, X., Chen, H. D. & Groisman, E. A. Gene expression kinetics governs
stimulus-specific decoration of the Salmonella outer membrane. Sci. Signal. 11,
eaar7921 (2018).
81. Laughlin, R. C. et al. Spatial segregation of virulence gene expression during
acute enteric infection with Salmonella enterica serovar Typhimurium. mBio 5,
e00946–00913 (2014).
82. Maldonado, R. F., Sá-Correia, I. & Valvano, M. A. Lipopolysaccharide modification
in Gram-negative bacteria during chronic infection. FEMS Microbiol. Rev. 40,
480–493 (2016).
83. Liu, Y. et al. Multi-omic measurements of heterogeneity in HeLa cells across
laboratories. Nat. Biotechnol. 37, 314–322 (2019).
84. Knodler, L. A. et al. Dissemination of invasive Salmonella via bacterial-induced
extrusion of mucosal epithelia. Proc. Natl Acad. Sci. USA 107, 17733–17738 (2010).
85. Kreibich, S. et al. Autophagy proteins promote repair of endosomal membranes
damaged by the Salmonella Type three secretion system 1. Cell Host Microbe 18,
527–537 (2015).
86. Cooper, K. G., Chong, A., Starr, T., Finn, C. E. & Steele-Mortimer, O. Predictable,
tunable protein production in salmonella for studying host-pathogen interac-
tions. Front. Cell. Infect. Microbiol. 7, 475 (2017).
87. Finn, C. E., Chong, A., Cooper, K. G., Starr, T. & Steele-Mortimer, O. A second wave
of Salmonella T3SS1 activity prolongs the lifespan of infected epithelial cells.
PLOS Pathog. 13, e1006354 (2017).
88. Lau, N. et al. SopF, a phosphoinositide binding effector, promotes the stability
of the nascent Salmonella-containing vacuole. PLoS Pathog. 15, e1007959
(2019).
89. Spinnenhirn, V. et al. The ubiquitin-like modifier FAT10 decorates autophagy-
targeted Salmonella and contributes to Salmonella resistance in mice. J. Cell Sci.
127, 4883–4893 (2014).
90. Ben-David, U. et al. Genetic and transcriptional evolution alters cancer cell line
drug response. Nature 560, 325–330 (2018).
91. Niepel, M. et al. A multi-center study on the reproducibility of drug-response
assays in mammalian cell lines. Cell Syst. 9, 35–48.e5 (2019).
92. Miao, E. A. et al. Caspase-1-induced pyroptosis is an innate immune effector
mechanism against intracellular bacteria. Nat. Immunol. 11, 1136–1142 (2010).
93. Cummings, L. A., Wilkerson, W. D., Bergsbaken, T. & Cookson, B. T. In vivo, fliC
expression by Salmonella enterica serovar Typhimurium is heterogeneous,
regulated by ClpX, and anatomically restricted. Mol. Microbiol. 61, 795–809
(2006).
94. Maltez, V. I. et al. Inflammasomes coordinate pyroptosis and natural killer cell
cytotoxicity to clear infection by a ubiquitous environmental Bacterium.
Immunity 43, 987–997 (2015).
95. Beuzón, C. R. et al. Salmonella maintains the integrity of its intracellular vacuole
through the action of SifA. EMBO J. 19, 3235–3249 (2000).
96. Wynosky-Dolfi, M. A. et al. Oxidative metabolism enables Salmonella evasion of
the NLRP3 inflammasome. J. Exp. Med. 211, 653–668 (2014).
97. Diard, M. et al. Inflammation boosts bacteriophage transfer between Salmonella
spp. Science 355, 1211–1215 (2017).
98. Runyen-Janecky, L. J. & Payne, S. M. Identification of chromosomal Shigella
flexneri genes induced by the eukaryotic intracellular environment. Infect.
Immun. 70, 4379–4388 (2002).
99. Coward, C. et al. The effects of vaccination and immunity on bacterial infection
dynamics in vivo. PLoS Pathog. 10, e1004359 (2014).
100. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis.
Nat. Methods 9, 676–682 (2012).
101. Weiss, G. L., Medeiros, J. M. & Pilhofer, M. In situ imaging of bacterial secretion
systems by electron cryotomography. Methods Mol. Biol. 1615, 353–375 (2017).
102. Medeiros, J. M. et al. Robust workflow and instrumentation for cryo-focused ion
beam milling of samples for electron cryotomography. Ultramicroscopy 190,
1–11 (2018).
103. Marko, M., Hsieh, C., Schalek, R., Frank, J. & Mannella, C. Focused-ion-beam
thinning of frozen-hydrated biological specimens for cryo-electron microscopy.
Nat. Methods 4, 215–217 (2007).
104. Mastronarde, D. N. Automated electron microscope tomography using robust
prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).
105. Mastronarde, D. N. Correction for non-perpendicularity of beam and tilt axis in
tomographic reconstructions with the IMOD package. J. Microsc. 230, 212–217
(2008).
106. Hoiseth, S. K. & Stocker, B. A. Aromatic-dependent Salmonella typhimurium are
non-virulent and effective as live vaccines. Nature 291, 238–239 (1981).
107. Hautefort, I., Proença, M. J. & Hinton, J. C. D. Single-copy green fluorescent
protein gene fusions allow accurate measurement of Salmonella gene expres-
sion in vitro and during infection of mammalian cells. Appl. Environ. Microbiol.
69, 7480–7491 (2003).
108. Stecher, B. et al. Flagella and chemotaxis are required for efficient induction of
Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated
mice. Infect. Immun. 72, 4138–4150 (2004).
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in anymedium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2020
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the. . .
A Hausmann et al.
544
Mucosal Immunology (2020) 13:530 – 544
